MCViewPoint

Opinion from a Libertarian ViewPoint

Posts Tagged ‘boosters’

You will NEVER be “fully vaccinated” – OffGuardian

Posted by M. C. on December 16, 2021

It’s time everyone realised they are chasing an intentionally impossible goal that will be pushed back over the horizon, forever.

https://off-guardian.org/2021/12/14/you-will-never-be-fully-vaccinated/

Kit Knightly

Yesterday, in a statement to Parliament on the UK’s planned “vaccine passport”, Health Secretary Sajid Javid admitted the NHS Pass would require three shots for you to be considered “fully vaccinated”.

“Once all adults have had a reasonable chance to get their booster jab, we intend to change this exemption to require a booster dose,”

While many of us predicted this would be the case, it is the first time any British politician has actually said it out loud, and in front of parliament too.

This incredibly cynical “evolving definition” of “fully vaccinated” is not a new phenomenon, and is not isolated to the UK either.

Israel changed their definition of “fully vaccinated” to include the booster months ago. New Zealand’s ministry of health is “considering” doing the same, as is Australia.

The EU isn’t far behind either, with proposals in place to make travel dependent on having a third dose.

The US hasn’t formally adopted a new definition yet, but you’d have to be blind not to see the signs. Just yesterday the LA Times headlined:

Should the definition of ‘fully vaccinated’ be changed to include a booster shot?

An article on Kaiser Health News asks the same thing.

Tony Fauci is quoted in the Independent as saying it’s only a matter of time before the definition is updated:

“It’s going to be a matter of when, not if” getting a booster shot will be considered being “fully vaccinated,” Dr Fauci said.

Opinion pieces are already appearing asking is it safe to hangout with the unboosted”?

(This headline was so unpopular, the Atlantic changed it only a couple of hours after it was published, and even the archived version appears to have been scrubbed).

All in all it seems pretty clear that, by the time 2022 rolls around, most of the Western world will require three shots in order to qualify as “fully vaccinated”.

It’s also clear that this won’t stop at three. Already, just last week, Pfizer were claiming they may need to “move up the timeline” for a fourth vaccine dose.

This change is being blamed on Omicron, with articles warning the “new variant” can “hit” the vaccinated. Fortune reports:

Omicron is making scientists redefine what it means to be ‘fully vaccinated’ against COVID

So, the third (and maybe fourth) doses are (allegedly) for Omicron…but that model can extend to perpetuity. In order to go to five, six or seven they’ll only need to “discover” more “new variants”.

It will just keep going and going.

But there is good news in all this, every time the powers-that-shouldn’t-be change the rules in the middle of the game, it’s a chance to knock people out of their media-induced hypnosis.

There are promising signs that millions of already-vaccinated will reject the booster. We can build on that.

So tell your single and double jabbed friends, try to open their eyes to the path they are starting down.

They may consider themselves “fully vaccinated”, but the government doesn’t, and never will.

Be seeing you

Posted in Uncategorized | Tagged: , , , , , , , , , , , , , , , , , | 1 Comment »

Erie Times E-Edition Article-Boosters were not tweaked for variants

Posted by M. C. on October 20, 2021

Could it be because anything other than what was approved under the EUA may not be immune from lawsuit prevention?

https://erietimes-pa-app.newsmemory.com/?publink=078fe2a40_1345f70

Lauran Neergaard

ASSOCIATED PRESS

More COVID-19 booster shots may be on the way – but when it’s your turn, you’ll get an extra dose of the original vaccine, not one updated to better match the extra-contagious delta variant.

And that has some experts wondering if the booster campaign is a bit of a missed opportunity to target delta and its likely descendants.

“Don’t we want to match the new strains that are most likely to circulate as closely as possible?” Dr. Cody Meissner of Tufts Medical Center, an adviser to the Food and Drug Administration, challenged Pfizer scientists recently.

“I don’t quite understand why this is not delta because that’s what we’re facing right now,” fellow adviser Dr. Patrick Moore of the University of Pittsburgh said last week as government experts debated whether it’s time for Moderna boosters. He wondered if such a switch would be particularly useful to block mild infection.

The simple answer: The FDA last month OK’d extra doses of Pfizer’s original recipe after studies showed it still works well enough against delta – and those doses could be rolled out right away. Now the FDA is weighing evidence for boosters of the original Moderna and Johnson & Johnson vaccines.

See COVID, Page 2A

In September, the FDA approved extra doses of Pfizer’s original COVID-19 vaccine after studies showed it still works well against the delta variant. CHARLES KRUPA/AP

Continued from Page 1A

“It’s less churn and burn on the manufacturing” to only switch formulas when it’s really necessary, said FDA vaccine chief Dr. Peter Marks.

But Pfizer and Moderna are hedging their bets. They’re already testing experimental doses customized to delta and another variant, learning how to rapidly tweak the formula in case a change eventually is needed – for today’s mutants or a brand new one. The tougher question for regulators is how they’d decide if and when to ever order such a switch.

What we know:

Current vaccines are working even against delta

Vaccines used in the U.S. remain strongly effective against hospitalization and death from COVID-19, even after the delta variant took over, but authorities hope to shore up waning protection against less severe infection and for high-risk populations. Studies show an extra dose of the original formulas revs up virus-fighting antibodies that fend off infection, including antibodies that target delta.

Vaccines target the spike protein that coats the coronavirus. Mutations in that protein made delta more contagious but to the immune system, it doesn’t look all that different, said virus expert Richard Webby of St. Jude Children’s Research Hospital.

That means there’s no guarantee a delta-specific booster would protect any better, said University of Pennsylvania immunologist John Wherry. Waiting for studies to settle that question – and if necessary, brewing updated doses – would have delayed rolling out boosters to people deemed to need them now.

Still, because delta is now the dominant version of the virus worldwide it almost certainly will be a common ancestor for whatever evolves next in a mostly unvaccinated world, said Trevor Bedford, a biologist and genetics expert at the Fred Hutchinson Cancer Research Center.

A delta-updated vaccine would “help to provide a buffer against those additional mutations,” he said. Bedford is paid by the Howard Hughes Medical Institute, which also supports The Associated Press Health and Science Department.

Tweaking the recipe

The Pfizer and Moderna vaccines are made with a piece of genetic code called messenger RNA that tells the body to make harmless copies of the spike protein so it’s trained to recognize the virus. Updating the formula merely requires swapping out the original genetic code with mRNA for a mutated spike protein.

Both companies first experimented with tweaked doses against a mutant that emerged in South Africa, the beta variant, that has been the most vaccineresistant to date, more so than the delta variant. Lab tests showed the updated shots produced potent antibodies. But the beta variant didn’t spread widely.

Now the companies have studies underway of fully vaccinated people who agreed to test a booster dose tweaked to match delta. Moderna’s studies also include some shots that combine protection against more than one version of the coronavirus – much like today’s flu vaccines work against multiple influenza strains.

The mRNA vaccines are considered the easiest kind to tweak but some other vaccine makers also are exploring how to change their recipes if necessary.

Why study updated shots if they’re not yet needed?

Moderna’s Dr. Jacqueline Miller told an FDA advisory panel last week the company is studying variant-specific boosters now to learn if they offer advantages, and to be ready if they’re needed.

And Penn’s Wherry said it is critical to carefully analyze how the body reacts to updated shots because the immune system tends to “imprint” a stronger memory of the first virus strain it encounters. That raises questions about whether a subtly different booster would prompt a temporary jump in antibodies the body’s made before – or the bigger goal, a broader and more durable response that might even be better positioned for the next mutations to come along.

No rules yet for making a switch

“What is the tripping point?” asked Webby, who is part of a World Health Organization network that tracks influenza evolution. “A lot of what is going to need to go into that decision making is just going to be learned by experience, unfortunately.”

Bedford said now is the time to decide what drop in vaccine effectiveness would trigger a formula change, just as is done with flu vaccines every year.

That’s important not just if a dramatically worse variant suddenly develops. Like many scientists, Bedford expects the coronavirus to eventually evolve from a global crisis into a regular threat every winter – which might mean more regular boosters, maybe even yearly in combination with the flu shot.

Timing between shots matters, too, Wherry noted.

“Your boostability may actually improve with longer intervals between stimulation,” he said. While scientists have learned a lot about the coronavirus, “the story’s not finished yet and we don’t know what the last chapters say.”

The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Department of Science Education. The AP is solely responsible for all content.

“A lot of what is going to need to go into that decision making is just going to be learned by experience, unfortunately.”

Richard Webby

St. Jude Children’s Research Hospital virus expert speaking about the decision to tweak boosters to match variants

Be seeing you

Posted in Uncategorized | Tagged: , , , | Leave a Comment »

Watch “INSANE! SpaceX Falcon Heavy Side Boosters Landing Simultaneously at Kennedy Space Center” on YouTube

Posted by M. C. on June 5, 2020

Elon! You do space better than cars.

Posted in Uncategorized | Tagged: , | Leave a Comment »